Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.
Trial locations(28 sites)
United States
Honor Health Research Institute, Scottsdale, Arizona Honor Health Research Institute, Scottsdale, Arizona National Institute Of Health, Bethesda, Maryland James Cancer Hospital and Solove Research Institute Ohio State, Columbus, Ohio Mary Crowley Cancer Research, Dallas, Texas Argentina
Novartis Investigative Site, Caba, Buenos Aires Austria
Novartis Investigative Site, Innsbruck, Tyrol China
Novartis Investigative Site, Beijing Denmark
Novartis Investigative Site, Copenhagen France
Novartis Investigative Site, Lyon Novartis Investigative Site, Nantes Novartis Investigative Site, Paris Novartis Investigative Site, Villejuif Germany
Novartis Investigative Site, Mannheim, Baden-Wurttemberg Novartis Investigative Site, Berlin Novartis Investigative Site, Hamburg Novartis Investigative Site, Heidelberg Hungary
Novartis Investigative Site, Debrecen, Hajdu Bihar Megye Novartis Investigative Site, Budapest Japan
Novartis Investigative Site, Kashiwa, Chiba Novartis Investigative Site, Chuo Ku, Tokyo Netherlands
Novartis Investigative Site, Rotterdam, South Holland Novartis Investigative Site, Utrecht Spain
Novartis Investigative Site, Barcelona Novartis Investigative Site, Madrid Novartis Investigative Site, Madrid Novartis Investigative Site, Madrid Thailand
Novartis Investigative Site, Songkhla, Hat Yai